Diabetes treatment is constantly evolving, with new therapeutic options appearing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a group of drugs that mimic the actions of https://jananilp887888.wikistatement.com/5345872/emerging_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment